Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT02667730 |
Other study ID # |
2013-12-126-004-0001 |
Secondary ID |
|
Status |
Completed |
Phase |
Phase 4
|
First received |
|
Last updated |
|
Start date |
June 2015 |
Est. completion date |
December 2021 |
Study information
Verified date |
February 2024 |
Source |
Canadian Department of National Defense |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
In this 4-arm pragmatic randomized control trial, the investigators hope to decipher whether
the use of non-opioid analgesics (naproxen, celecoxib, acetaminophen) in addition to
standardized physiotherapy during the acute phase of grade I-II ankle injuries will result in
functional differences compared to standardized physiotherapy alone
Description:
Background Ankle sprains occur frequently in the Canadian Armed Forces (CAF) population and
account for a significant proportion of lost work time. Equally significant is the use of
analgesics (NSAID or non-NSAID) (NSAID = non steroidal anti-inflammatory drug) in the CAF
population. Existing literature suggests that the rate and extent of soft tissue healing may
be adversely affected by use of some analgesics, particularly non-steroidal anti-inflammatory
agents (NSAIDs), when these are used immediately following joint injury. There have been two
postulated mechanisms for this observation: the first being that inflammatory markers are
required in the regeneration process; the second is that the diminished pain level as a
result of analgesic use encourages overuse of the injured tissue. Unfortunately, the science
is far from conclusive, since much of it is derived based on isolated exercises, conducted in
experimental settings, in older populations, or extrapolated from biomarkers that have not
been validated for clinical relevance. While there is no current standard of practice
regarding the use of pain relievers following ankle injury, this practice continues to be
widespread in the CAF.
Goal The proposed study aims to clarify whether three commonly used non-opioid pain relievers
provide additional benefit or delay improvement in ankle function following mild ankle
sprains, when compared to standardized physiotherapy treatment alone. The three agents
investigated will be 1) the non-steroid anti-inflammatory drug naproxen, 2) the selective
anti-inflammatory celecoxib, and 3) the centrally-acting analgesic acetaminophen.
Methods Patients presenting to the health clinic at Garrison Petawawa with acute ankle
injuries will be screened for study eligibility. All individuals who elect to participate in
this study will be referred for standardized physiotherapy treatment, which will be
administered according to study protocol. Participants will also be randomized to one of four
analgesic treatment groups (i.e., naproxen, celecoxib, acetaminophen, or non-pharmacological
measures only), with stratification for grade of ankle injury. Physiotherapists who are
blinded to analgesic treatment allocation will evaluate participants' ankle function at 72
hours, 2 weeks, 3 months and 1 year post-injury, using previously validated tests.
Pharmacists will assess response to drug therapy, side effects, and use of rescue medications
at day 7 following enrollment. Occurrence of repeat ankle injuries and health resource
consumption (i.e., specialist visits and diagnostic imaging) will also be assessed for the
year following index injury.
Risks This study is intended to be low risk to participants as it is designed to closely
mirror existing practices for such injuries. All medications used in this study are indicated
for soft tissue injuries and their respective dosages/frequencies/durations aligned with
manufacturer recommendations. The physiotherapy intervention was developed by Dr. Eric
Robitaille. It has been used in previous studies and is currently in use in the CAF. The
investigators do not expect the risk of injury to be higher than that associated with
existing practices for ankle injuries.
Benefits Participants are expected to benefit from the direct application of a standardized
physiotherapy treatment protocol for overall management of their condition as well as the
pain relief from the analgesic options. The results of this study are expected to generate
new information that can be readily applied to patient care, specifically in treating a
frequently-occurring soft tissue injury in the CAF population.